Literature DB >> 6309003

Elevated serum angiotensin-converting enzyme in hyperthyroidism.

E Silverstein, G C Schussler, J Friedland.   

Abstract

Serum angiotensin-converting enzyme was elevated in patients with hyperthyroidism (72 +/- 31 nmol/minute/ml, n = 12, p less than 0.001) but not in patients with hypothyroidism (38 +/- 3, n = 3) or thyroiditis (26, n = 1), and was positively correlated in 23 patients with serum thyroxine concentration (r = 0.60, p less than 0.01) and triiodothyronine resin uptake (r = 0.56, p less than 0.01). Triiodothyronine failed to enhance the synthesis of angiotensin-converting enzyme in rabbit alveolar macrophages or in human monocytes in culture, suggesting that the increased serum enzyme is a consequence of an effect other than increased angiotensin-converting enzyme synthesis. Hyperthyroidism should be considered in the evaluation of serum angiotensin-converting enzyme for the diagnosis and management of sarcoidosis.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6309003     DOI: 10.1016/0002-9343(83)91198-1

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  5 in total

1.  Serum angiotensin converting enzyme in pneumonias.

Authors:  Y Kerttula; T H Weber
Journal:  J Clin Pathol       Date:  1986-11       Impact factor: 3.411

2.  Comparison of serum angiotensin-converting enzyme in Graves' disease, toxic nodular goiter, and other thyroid conditions.

Authors:  H Czernobilsky; W Fiehn; R Ziegler
Journal:  Klin Wochenschr       Date:  1985-06-03

Review 3.  Prospective role of thyroid disorders in monitoring COVID-19 pandemic.

Authors:  Kanchan Kumari; Gagan B N Chainy; Umakanta Subudhi
Journal:  Heliyon       Date:  2020-12-13

4.  Changes of serum angiotensin-converting enzyme activity during treatment of patients with Graves' disease.

Authors:  D S Lee; J K Chung; B Y Cho; C S Koh; M Lee
Journal:  Korean J Intern Med       Date:  1986-01       Impact factor: 2.884

5.  Effects of Antihypertensive Drugs on Thyroid Function in Type 2 Diabetes Patients With Euthyroidism.

Authors:  Lijuan Yang; Xiuqin Sun; Yi Zhao; Hong Tao
Journal:  Front Pharmacol       Date:  2022-03-07       Impact factor: 5.810

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.